Deveci, O. Et Al. 2015. Novel BioTarget in Treatment of Heart Failure: Changes in Serum Galectin-3 Levels After Spironolacton therapy.. JOURNAL OF HYPERTENSION: Open Access , vol.4, no.1 , 1-4.

Deveci, O., Çelik, A., İkikardeş, M., Çağlayan, Ç., Özmen, Ç., Deniz, A., ... Eker Akıllı, R.(2015). Novel BioTarget in Treatment of Heart Failure: Changes in Serum Galectin-3 Levels After Spironolacton therapy.. JOURNAL OF HYPERTENSION: Open Access , vol.4, no.1, 1-4.

Deveci, O.S. Et Al. "Novel BioTarget in Treatment of Heart Failure: Changes in Serum Galectin-3 Levels After Spironolacton therapy.," JOURNAL OF HYPERTENSION: Open Access , vol.4, no.1, 1-4, 2015

Deveci, O.S. Et Al. "Novel BioTarget in Treatment of Heart Failure: Changes in Serum Galectin-3 Levels After Spironolacton therapy.." JOURNAL OF HYPERTENSION: Open Access , vol.4, no.1, pp.1-4, 2015

Deveci, O. Et Al. (2015) . "Novel BioTarget in Treatment of Heart Failure: Changes in Serum Galectin-3 Levels After Spironolacton therapy.." JOURNAL OF HYPERTENSION: Open Access , vol.4, no.1, pp.1-4.

@article{article, author={O.S. Deveci Et Al. }, title={Novel BioTarget in Treatment of Heart Failure: Changes in Serum Galectin-3 Levels After Spironolacton therapy.}, journal={JOURNAL OF HYPERTENSION: Open Access}, year=2015, pages={1-4} }